Thursday, April, 18, 2019 08:52:45

Voluntis & AbbVie team up to develop companion digital therapeutics

Voluntis, a company specializing in digital therapeutics, has reportedly announced that it has formed a collaboration with research-based global biopharmaceutical company AbbVie, in order to improve patient care coordination in immunology through innovative digital therapeutic software. As per trusted sources, the companies will collectively leverage …

Aduro Biotech & Lilly to collaborate for R&D of novel immunotherapies

The U.S.-based global pharmaceutical firm Eli Lilly & Company, and California-based immunotherapy company, Aduro Biotech, are currently in the news for announcing a research collaboration, as well as an exclusive license deal, for the cGAS-STING pathway inhibitor program that would develop new immunotherapies for inflammatory …

Distributed Bio forms multi-target partnership with Good Therapeutics

Distributed Bio, which a global leader in computational optimization of fully human monoclonal antibody libraries, has recently made an announcement confirming a multi-target collaboration with Seattle-based Good Therapeutics Inc. According to BioSpace, Distributed Bio, under the partnership, would be using its SuperHuman antibody library platform …

FDA clears Pear Therapeutics’ mobile medical app to treat opioid abuse

 The medical mobile application is specifically developed to boost patient retention at facilities that treat opioid abuse.  The app is intended to be utilized alongside other treatments under a healthcare professional’s supervision. Pear Therapeutics, a renowned U.S-based biotech firm, has reportedly announced that its mobile …